Tango Therapeutics, Inc. — 10-Q Filings
16 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Tango Therapeutics, Inc. (TNGX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Tango Therapeutics, Inc. has filed 16 10-Q documents with the SEC since 2020. To view all SEC filings by Tango Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-263680 | Nov 4, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-102392 | Aug 5, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-068549 | May 12, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-121818 | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-092274 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-055065 | May 8, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-060682 | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-038750 | Aug 7, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-019140 | May 9, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-024219 | Nov 10, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-016257 | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-009139 | May 11, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0000950170-21-003734 | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | QUARTERLY REPORT | 0001213900-21-040828 | Aug 9, 2021 | Jun 30, 2021 |
| 10-Q | QUARTERLY REPORT | 0001213900-21-026397 | May 14, 2021 | Mar 31, 2021 |
| 10-Q | QUARTERLY REPORT | 0001213900-20-036927 | Nov 13, 2020 | Sep 30, 2020 |